Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 961-970 of 3427 for cancer

Edit search filters
  1. An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

    Rochester, MN

  2. A Study to Evaluate Gleolan to Enhance Tumor Visualization in Patients with Newly-diagnosed or Recurrent Meningioma

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study to Examine the Effect of Ginger on the Gut Microbiome

    Mankato, MN

  4. An Open Label Extension Study of BMS-911543 In Subjects With Myelofibrosis

    Rochester, MN

  5. A Study of Disulfiram and Chemotherapy in Pancreas Cancer Patients

    Rochester, MN

  6. Safety of MT-401-OTS in Patients with Relapsed AML or MDS

    Jacksonville, FL

  7. Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma

    Jacksonville, FL, Rochester, MN

  8. Venetoclax And Vincristine Liposomal In Treating Patients With Relapsed Or Refractory T-cell Or B-cell Acute Lymphoblastic Leukemia

    Rochester, MN

  9. Prehabilitation

    Rochester, MN

  10. A Study to Determine Number of Rounds of Plasma Exchange Needed to Decrease Measles Virus Antibodies for Measles Virus Cancer Therapy

    Rochester, MN

.

Mayo Clinic Footer